TRX THERAPEUTICS AS
Operating
Investeringer i aksjer, selskapsandeler og immaterielle eiendeler samt
forskning, utvikling og kommersialisering av legemidler og medisinske
behandlingsformer.
Investeringer i aksjer og rettigheter. Utvikling og salg av
legemidler.
Organization
- CEO
- JP
- Chairman of the board
- FL
- Years since formation
- 4 years
- since Apr 14, 2021
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 2
- persons
Financials
- Total equity 2024
- 30,000
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JP | Managing Director/CEO | 50 % directly |
Board
| Name | Role | Shares |
|---|---|---|
FL | Chairman | 50 % directly |
JP | Board Member | 50 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JP | Managing Director/CEO, Board Member | 50 % directly |
FL | Chairman | 50 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
FL | Ordinary shares | 500 | 50 % |
JP | Ordinary shares | 500 | 50 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | 0 | 0 | 0 | 0 |
Total assets | 30,000 | 30,000 | 30,000 | 30,000 |
Total liabilities | 0 | 0 | 0 | 0 |
Total equity | 30,000 | 30,000 | 30,000 | 30,000 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 0 | 0 | 0 | 0 |
Operating result | 0 | 0 | 0 | 0 |
Financial income/costs | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 0 | 0 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | 0 | 0 | 0 | 0 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 30,000 | 30,000 | 30,000 | 30,000 |
Total assets | 30,000 | 30,000 | 30,000 | 30,000 |
Short term debt | 0 | 0 | 0 | 0 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 0 | 0 | 0 | 0 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | 0 | 0 | 0 | 0 |
Total equity | 30,000 | 30,000 | 30,000 | 30,000 |
Total equity and liabilities | 30,000 | 30,000 | 30,000 | 30,000 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises